Impact of post-implant dosimetric parameters on the quality of life of patients treated with low-dose rate brachytherapy for localised prostate cancer: results of a single-institution study.

Radiat Oncol · 2015 · PMC4464626 · PMID 26054532

Europe PMC DOI

hedged sentence

0.0560

closest p · 1.1× alpha

0.0560

boldest claim

The sentences

of borderline significancep = 0.056so close (0.05 < p ≤ 0.1)

There was no statistically significant difference from baseline in the REL scale after one, two or three years, but the difference was of borderline significance one month post-implantation ( p = 0.056).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.